Navigation Links
New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture
Date:10/10/2008

Leading researchers in academia and industry reveal powerful effects of recombinant lactoferrin (tradename: Lacromin) in mammalian cell culture

leading to a significant boost in productivity.

FORT COLLINS, Colo., Oct. 10 /PRNewswire/ -- A recently published study in the scientific journal In Vitro Cellular & Developmental Biology revealed that recombinant lactoferrin (tradename: Lacromin, see http://www.Lacromin.com) is a strong growth factor for promoting cell growth and cell productivity across a variety of cell lines, including intestinal cells, hybridoma cells, osteoblast cells and embryonic kidney (293) cells.

A global collaborative research effort led to the findings. The study included research conducted by two prestigious international research institutions: University of Auckland in New Zealand and Barts & The London Queen Mary's School of Medicine & Dentistry in London. Also, cell culture industry researchers at the following companies contributed to these findings:

-- HyClone Inc in Logan, Utah;

-- KC Bio in Kansas City, Missouri; and

-- InVitria in Fort Collins, Colorado.

Dr. Ning Huang, Vice President of Research and Development for InVitria, coordinated the study entitled, "Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth (1)."

"In working with research collaborators in the industry and leading academic centers around the world, recombinant lactoferrin has been shown to promote cell growth and productivity in a variety of cell lines and also improves antibody product yields in mammalian cell culture," said Dr. Huang. "Since recombinant lactoferrin is well defined, it is an important component for adapting cells and transitioning cells from serum to animal free and completely defined cell culture media."

"We have discovered that recombinant lactoferrin is an important growth factor in bone cell culture media," said Professor Jillian Cornish, Department of Medicine, Faculty of Health and Medical Sciences at University of Auckland. "Not only did we see improved growth of osteoblasts, but we also found that growth increased with greater amounts of recombinant lactoferrin."

About InVitria (http://www.InVitria.com)

InVitria has developed cell culture media components that enhance productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. InVitria's recombinant human lactoferrin called Lacromin (http://www.Lacromin.com) was utilized in this study.

For more detailed product information requests or to order re-prints of the above-mentioned article contact InVitria by e-mail or phone.

E-mail: info@InVitria.com Phone: 1-800-916-8311

(1) Huang, N. et al. Bioactive recombinant human lactoferrin, derived from

rice, stimulates mammalian cell growth. In Vitro Cellular &

Developmental Biology. September 19, 2008 (E-publication Date).


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Facet Solutions Completes Facet Joint and Disc Replacement Study
2. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
3. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
4. Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment
5. Eklin Medical Surpasses 1,000th RapidStudy(R) Digital Radiography System Installation Featuring Canon DR Technology
6. Oil palm plantations are no substitute for tropical rainforests, a new study shows
7. Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures
8. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
9. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
10. Germicidal UVC Lights Improve Clinical Pregnancy Rates for IVF Lab, New Study Finds
11. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... launched Rosalind™, the first-ever genomics analysis platform specifically designed for life science ... in honor of pioneering researcher Rosalind Franklin, who made a major contribution ...
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):